Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma

Monoamine oxidase inhibitors (MAOIs) are an important class of drugs prescribed for treatment of depression and other neurological disorders. Evidence has suggested that patients with atypical depression preferentially respond to natural product MAOIs. This review presents a comprehensive survey of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaurasiya, Narayan D., Leon, Francisco, Muhammad, Ilias, Tekwani, Babu L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268457/
https://www.ncbi.nlm.nih.gov/pubmed/35807542
http://dx.doi.org/10.3390/molecules27134297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268457/
https://www.ncbi.nlm.nih.gov/pubmed/35807542
http://dx.doi.org/10.3390/molecules27134297

Ejemplares similares